Drawing for NORTHERN LIPIDS

USPTO serial 79460252

NORTHERN LIPIDS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with NORTHERN LIPIDS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry with exception of manures; chemical auxiliaries and intermediate products for the manufacture of pharmaceutical and cosmetic products; unprocessed artificial resins, unprocessed plastics; unprocessed artificial resins in the form of powders, granules, solutions, emulsions, dispersions, and pastes, in particular for use as auxiliaries for the manufacture of pharmaceutical products; biodegradable polymers for medical and pharmaceutical use; acrylic polymers for medical and pharmaceutical use; polymethymethacrylate; lactides for industrial purposes, lactides for use in pharmaceuticals, lactides for use in manufacture, lactides for use in the manufacture of pharmaceutical products; glycolides for industrial purposes, glycolides for use in pharmaceuticals, glycolides for use in manufacture, glycolides for use in the manufacture of pharmaceutical products; dioxanones; trimethylene carbonates; caprolactones; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.ACTIVE—
005Pharmaceutical and veterinary preparations; medical and veterinary preparations and articles (included in this class); adjuvants for medical purposes; coatings, lacquers and glazes for pharmaceutical and veterinary preparations as well as for dietetic substances included in this class; chemical preparations for medical, pharmaceutical, veterinary and hygienic purposes (included in this class); esters for pharmaceutical purposes; diagnostic preparations for medical purposes; gum and gamboge for medical purposes; chemical-pharmaceutical preparations; surgical implants grown from living cells; capsules for medical purposes; hygienic preparations and articles; hygienic preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietetic preparations and nutritional supplements; dietetic substances adapted for medical use; food for babies; plasters; materials for dressings; material for stopping teeth, dental impression materials; disinfectants; preparations for destroying vermin; fungicides; herbicides.ACTIVE—
040Treatment of materials, namely processing of chemical and pharmaceutical polymers for the manufacture of chemical, pharmaceutical and veterinary preparations; custom manufacture of chemical, pharmaceutical and veterinary products by means of microencapsulating techniques for others; treatment of materials, namely processing of biodegradable polymers for medical applications, in particular tissue replacement, bone formation and bone fixation as well as for the manufacture of chemical, pharmaceutical and veterinary preparations; treatment of materials, namely processing of chemical and pharmaceutical preparations for the controlled release of active ingredients in chemical, pharmaceutical and veterinary preparations; treatment of materials, namely processing of chemical and pharmaceutical preparations used for surgical, medical, dental and veterinary apparatus and instruments as well as diagnostic apparatus for medial use and apparatus for use in medical analysis; treatment of materials, namely processing of biodegradable polymers for the manufacture of artificial limbs, artificial implants, stents, syringes for medical purposes, catheter, cannula, acupuncture needles, suture needles, artificial limbs, eyes and teeth, medical guidewires, orthopedic articles, suture materials; custom manufacturing services in the field of material processing.ACTIVE—
042Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; technical consultancy in the field of the manufacture of chemical, pharmaceutical and veterinary preparations using chemical and pharmaceutical polymers; technical consultancy in the field of the use of biodegradable polymers for medical applications; quality control and material testing; expert opinion relating to technology; materials testing and analysis; chemistry services; engineering services; bacteriological or chemical laboratory services; physics (research).ACTIVE—
044Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services; consultancy and information services in the field of manufacture of pharmaceuticals.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 21, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 21, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 8, 2026SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance